Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3Urinary Retention 2Urinary Bladder Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Lung Neoplasms 1Disease Progression 1

Interventions

Dutasteride 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Transurethral Resection of Prostate 2Therapeutics 2Radiotherapy 2Prostatectomy 2Blood Specimen Collection 2proxalutamide 1polyphenon E 1mirabegron 1Urination 1TroVax 1Transurethral Resection of Bladder 1Tamsulosin 1Standard of Care 1Risedronic Acid 1Psychiatric Rehabilitation 1Prostate-Specific Antigen 1Papaverine 1Oxygen 1Nitrous Oxide 1Needles 1Microspheres 1Magnetic Resonance Spectroscopy 1Lycopene 1Levofloxacin 1Finasteride 1Electroacupuncture 1Doxazosin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Hyperplasia × Tamsulosin × Clear all
NCT05834270 2023-04-28

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Menoufia University

Phase NA Completed
60 enrolled
Genitourinary

Prostatic Diseases, Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡